CA2033176A1 - Proteines de fusion d'hormones de croissance - Google Patents
Proteines de fusion d'hormones de croissanceInfo
- Publication number
- CA2033176A1 CA2033176A1 CA2033176A CA2033176A CA2033176A1 CA 2033176 A1 CA2033176 A1 CA 2033176A1 CA 2033176 A CA2033176 A CA 2033176A CA 2033176 A CA2033176 A CA 2033176A CA 2033176 A1 CA2033176 A1 CA 2033176A1
- Authority
- CA
- Canada
- Prior art keywords
- growth hormone
- growth
- polypeptide
- fusion proteins
- fusion protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormones [GH] (Somatotropin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
L'invention se rapporte à un plasmide codant pour une protéine de fusion, comprenant un premier polypeptide produisant une activité d'hormone de croissance et un second polypeptide, lequel peut être constitué par un polypeptide du facteur de croissance d'insuline (IGF)-I ou IGF-II et de leurs analogues, de l'histone de poulet H2A.I ou des facteurs de transcription humaine SPI-Lac Z, une séquence de clivage optionnelle pouvant être placée entre le premier et le seocnd polypeptide. Cette protéine de fusion peut être utilisée: 1) pour traiter des déficiences de l'hormone de croissance; 2) pour supprimer les pertes de protéines corporelles à la suite d'un trauma, tel que brûlures ou infections; 3) pour augmenter les taux de croissance et l'efficacité de la transformation des aliments chez les animaux d'élevage; et 4) pour soutenir la croissance de cellules en culture.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPJ4672 | 1989-06-09 | ||
AUPJ467289 | 1989-06-09 | ||
PCT/AU1990/000210 WO1990015142A1 (fr) | 1989-06-09 | 1990-05-22 | Proteines de fusion pour hormones de croissance |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2033176A1 true CA2033176A1 (fr) | 1990-12-10 |
CA2033176C CA2033176C (fr) | 1999-12-14 |
Family
ID=3773983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002033176A Expired - Lifetime CA2033176C (fr) | 1989-06-09 | 1990-05-22 | Proteines de fusion d'hormones de croissance |
Country Status (6)
Country | Link |
---|---|
US (1) | US5330971A (fr) |
EP (1) | EP0429586B1 (fr) |
AT (1) | ATE125869T1 (fr) |
CA (1) | CA2033176C (fr) |
DE (1) | DE69021335T2 (fr) |
WO (1) | WO1990015142A1 (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5977307A (en) * | 1989-09-07 | 1999-11-02 | Alkermes, Inc. | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
ATE165008T1 (de) * | 1990-02-13 | 1998-05-15 | Gropep Pty Ltd | Methode zur behandlung intestinaler krankheiten |
US5679771A (en) * | 1990-02-13 | 1997-10-21 | Gropep Pty. Ltd. | Method for treating intestinal diseases |
US5210017A (en) * | 1990-11-19 | 1993-05-11 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
ATE314479T1 (de) * | 1992-05-18 | 2006-01-15 | Genentech Inc | Aktivierung von rezeptoren fähig zur oligomerisierung durch verwendung von fusionierten rezeptor liganden |
US5684136A (en) * | 1992-05-18 | 1997-11-04 | Genentech, Inc. | Chimeric hepatocyte growth factor (HGF) ligand variants |
WO1993025226A1 (fr) * | 1992-06-08 | 1993-12-23 | Kabi Pharmacia Ab | Utilisation du facteur de croissance igf-i et/ou igf-ii |
NZ243071A (en) * | 1992-06-08 | 1994-09-27 | Kabi Pharmacia Ab | Igf-2 (or analogue) compositions for pharmaceutical uses |
US5444045A (en) * | 1992-09-17 | 1995-08-22 | Gropep, Pty. Ltd. | Method of administering IGF-1, IGF-2, and analogs thereof to birds |
AU1178395A (en) * | 1993-11-12 | 1995-05-29 | North Shore University Hospital Research Corporation | Method of treating muscular dystrophy |
GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
CA2321026A1 (fr) * | 1998-03-09 | 1999-09-16 | Zealand Pharmaceuticals A/S | Conjugues peptidiques pharmacologiquement actifs ayant une tendance reduite a l'hydrolyse enzymatique |
AUPP298498A0 (en) * | 1998-04-17 | 1998-05-07 | Gropep Pty Ltd | Matrix binding factor |
WO2000034312A1 (fr) * | 1998-12-10 | 2000-06-15 | Samyang Genex Corporation | Procede de purification de peptides antimicrobiens |
AUPQ387599A0 (en) * | 1999-11-05 | 1999-12-02 | Metabolic Pharmaceuticals Limited | Product and method for control of obesity |
CN1296974A (zh) * | 1999-11-23 | 2001-05-30 | 上海博容基因开发有限公司 | 一种新的多肽——人组蛋白h2a.21和编码这种多肽的多核苷酸 |
JP2003530839A (ja) | 2000-04-12 | 2003-10-21 | プリンシピア ファーマスーティカル コーポレイション | アルブミン融合タンパク質 |
US6946134B1 (en) | 2000-04-12 | 2005-09-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
JP4173732B2 (ja) * | 2000-11-28 | 2008-10-29 | プレマキュア・アクチボラグ | 未熟児合併症のリスクの決定および治療 |
US20060084794A1 (en) * | 2001-04-12 | 2006-04-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20050244931A1 (en) * | 2001-04-12 | 2005-11-03 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20050054051A1 (en) * | 2001-04-12 | 2005-03-10 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7507413B2 (en) | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
WO2003030821A2 (fr) * | 2001-10-05 | 2003-04-17 | Human Genome Sciences, Inc. | Proteines de fusion d'albumine |
WO2005003296A2 (fr) | 2003-01-22 | 2005-01-13 | Human Genome Sciences, Inc. | Proteines hybrides d'albumine |
EP2261250B1 (fr) | 2001-12-21 | 2015-07-01 | Human Genome Sciences, Inc. | Protéines de fusion d'albumine et GCSF |
US7355018B2 (en) | 2003-09-30 | 2008-04-08 | Regeneron Pharmaceuticals, Inc. | Modified IGF1 polypeptides with increased stability and potency |
ES2541810T3 (es) * | 2005-01-07 | 2015-07-24 | Regeneron Pharmaceuticals, Inc. | Polipéptidos de fusión IGF-1 y usos terapéuticos de los mismos |
EP1841443A4 (fr) * | 2005-01-11 | 2012-05-02 | Heart Failure Technologies Inc | Methode et systeme pour le traitement de l'insuffisance cardiaque |
WO2007068053A1 (fr) * | 2005-12-15 | 2007-06-21 | Gropep Limited | Production de protéines par voie recombinante |
WO2008035230A2 (fr) * | 2006-09-18 | 2008-03-27 | Novozymes Gropep Limited | Compositions protéiques liquides |
PE20161326A1 (es) | 2014-04-10 | 2016-12-11 | Bayer Healthcare Llc | Formulacion en polvo de medio de compuesto y metodo de preparacion de medio liquido para cultivo celular |
US11136551B2 (en) | 2015-09-01 | 2021-10-05 | Ncardia B.V. | In vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell population |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK108685A (da) * | 1984-03-19 | 1985-09-20 | Fujisawa Pharmaceutical Co | Vaekstfaktor i |
US5028531A (en) * | 1984-03-19 | 1991-07-02 | Fujisawa Pharmaceutical Company, Ltd. | IGF-I fusion proteins; protection of IGF-I from degradation by host cell; and processes for the production thereof |
WO1987001038A1 (fr) * | 1985-08-22 | 1987-02-26 | Commonwealth Scientific And Industrial Research Or | Analogues peptidiques du facteur de croissance 1 similaire a l'insuline chez les mammiferes |
AU613876B2 (en) * | 1986-10-01 | 1991-08-15 | Merck & Co., Inc. | Synthetic genes encoding proteins from plasmid containing eucaryotic secretory signal peptides and process for secreting encoded proteins |
FR2619719B1 (fr) * | 1987-09-01 | 1991-05-10 | Sanofi Sa | Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices |
JPH01144981A (ja) * | 1987-12-02 | 1989-06-07 | Wakunaga Pharmaceut Co Ltd | 蛋白質の製造 |
WO1989005822A1 (fr) * | 1987-12-24 | 1989-06-29 | Gropep Pty. Ltd. | Analogues peptidiques du facteur 1 (igf-1) ou du facteur 2 (igf-2) de croissance similaire a l'insuline |
-
1990
- 1990-05-22 EP EP90908176A patent/EP0429586B1/fr not_active Expired - Lifetime
- 1990-05-22 US US07/646,616 patent/US5330971A/en not_active Expired - Lifetime
- 1990-05-22 AT AT90908176T patent/ATE125869T1/de not_active IP Right Cessation
- 1990-05-22 DE DE69021335T patent/DE69021335T2/de not_active Expired - Lifetime
- 1990-05-22 WO PCT/AU1990/000210 patent/WO1990015142A1/fr active IP Right Grant
- 1990-05-22 CA CA002033176A patent/CA2033176C/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1990015142A1 (fr) | 1990-12-13 |
DE69021335D1 (de) | 1995-09-07 |
DE69021335T2 (de) | 1996-04-11 |
EP0429586A4 (en) | 1992-07-08 |
EP0429586B1 (fr) | 1995-08-02 |
US5330971A (en) | 1994-07-19 |
ATE125869T1 (de) | 1995-08-15 |
EP0429586A1 (fr) | 1991-06-05 |
CA2033176C (fr) | 1999-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2033176A1 (fr) | Proteines de fusion d'hormones de croissance | |
EP0161640A3 (fr) | Cellules de souris enkystées et transformées avec l'ADN rétrovirus aviaire-hormone de croissance bovine et un procédé pour administrer la BGH in vivo | |
IE811463L (en) | Interferons | |
NZ227788A (en) | Peptide having growth hormone regulatory effects, and compositions | |
HK1005594A1 (en) | Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4) | |
IL96723A0 (en) | Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof | |
AU7681687A (en) | Expression of platelet-derived growth factor and analogues | |
AU601959B2 (en) | GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use | |
WO2000034474A3 (fr) | Zvegf3 homologue du facteur de croissance | |
AU2308992A (en) | Cysteine depleted il-6 muteins | |
EP0181634A3 (fr) | Gène synthétique pour lysozyme humaine | |
IE871871L (en) | Cloning and expression of acidic fibroblast growth factor | |
NZ235743A (en) | Food additives promoting ice nucleation containing proteins carried by gras microorganisms, plasmids and recombinant host cells | |
EP0232107A3 (fr) | Dérivé du polypeptide de la lymphotoxine humaine | |
EP0315118A3 (fr) | ADN codant pour endothéline et son utilisant | |
AU590861B2 (en) | New human lymphotoxin (TNF-beta) polypeptides their prepartion and use | |
JPS6420086A (en) | Polypeptide and production thereof | |
SE9403055D0 (sv) | A new human peptide antibiotic (FALL-39) and its use | |
MY100892A (en) | Veterinary preparations. | |
AU2140695A (en) | Recombinant viruses coding for a glutamate decarboxylase (gad) activity | |
CA2004764A1 (fr) | Proteines ancrod, leur preparation et leur utilisation | |
高亚胜 et al. | A PRIMARY OBSERVATION OF TPA EFFECT ON SSV-NIH3T3 CELLS IN SERUM-FREE MEDIUM | |
CA2236679A1 (fr) | Polypeptide suppresseur et de differenciation | |
NO941982L (no) | Fremstilling av proteiner ved anvendelse av 7B2 protein | |
Bukhalo et al. | Identification of the strain Polyporus squamosus Huds. ex Fr. PS-64 to be used as a producer of food biomass, as Fusarium sambucinum var. ossicolum(Berk. and Curt.). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |